These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Schmidt L; Duh FM; Chen F; Kishida T; Glenn G; Choyke P; Scherer SW; Zhuang Z; Lubensky I; Dean M; Allikmets R; Chidambaram A; Bergerheim UR; Feltis JT; Casadevall C; Zamarron A; Bernues M; Richard S; Lips CJ; Walther MM; Tsui LC; Geil L; Orcutt ML; Stackhouse T; Lipan J; Slife L; Brauch H; Decker J; Niehans G; Hughson MD; Moch H; Storkel S; Lerman MI; Linehan WM; Zbar B Nat Genet; 1997 May; 16(1):68-73. PubMed ID: 9140397 [TBL] [Abstract][Full Text] [Related]
7. The genetic basis of cancer of the kidney. Linehan WM; Walther MM; Zbar B J Urol; 2003 Dec; 170(6 Pt 1):2163-72. PubMed ID: 14634372 [TBL] [Abstract][Full Text] [Related]
8. Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Schmidt L; Junker K; Nakaigawa N; Kinjerski T; Weirich G; Miller M; Lubensky I; Neumann HP; Brauch H; Decker J; Vocke C; Brown JA; Jenkins R; Richard S; Bergerheim U; Gerrard B; Dean M; Linehan WM; Zbar B Oncogene; 1999 Apr; 18(14):2343-50. PubMed ID: 10327054 [TBL] [Abstract][Full Text] [Related]
9. Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients. Salvi A; Marchina E; Benetti A; Grigolato P; De Petro G; Barlati S Int J Oncol; 2008 Aug; 33(2):271-6. PubMed ID: 18636147 [TBL] [Abstract][Full Text] [Related]
10. Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management. Maher ER World J Urol; 2018 Dec; 36(12):1891-1898. PubMed ID: 29680948 [TBL] [Abstract][Full Text] [Related]
12. Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumours. Fischer J; Palmedo G; von Knobloch R; Bugert P; Prayer-Galetti T; Pagano F; Kovacs G Oncogene; 1998 Aug; 17(6):733-9. PubMed ID: 9715275 [TBL] [Abstract][Full Text] [Related]
13. Hereditary Renal Cancer Syndromes. Yanus GA; Kuligina ES; Imyanitov EN Med Sci (Basel); 2024 Feb; 12(1):. PubMed ID: 38390862 [TBL] [Abstract][Full Text] [Related]
14. Papillary renal cell carcinoma: analysis of germline mutations in the MET proto-oncogene in a clinic-based population. Lindor NM; Dechet CB; Greene MH; Jenkins RB; Zincke MT; Weaver AL; Wilson M; Zincke H; Liu W Genet Test; 2001; 5(2):101-6. PubMed ID: 11551094 [TBL] [Abstract][Full Text] [Related]
16. Novel germline MET pathogenic variants in French patients with papillary renal cell carcinomas type I. Sebai M; Tulasne D; Caputo SM; Verkarre V; Fernandes M; Guérin C; Reinhart F; Adams S; Maugard C; Caron O; Guillaud-Bataille M; Berthet P; Bignon YJ; Bressac-de Paillerets B; Burnichon N; Chiesa J; Giraud S; Lejeune S; Limacher JM; de Pauw A; Stoppa-Lyonnet D; Zattara-Cannoni H; Deveaux S; Lidereau R; Richard S; Rouleau E Hum Mutat; 2022 Mar; 43(3):316-327. PubMed ID: 34882875 [TBL] [Abstract][Full Text] [Related]
17. Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family. Olivero M; Valente G; Bardelli A; Longati P; Ferrero N; Cracco C; Terrone C; Rocca-Rossetti S; Comoglio PM; Di Renzo MF Int J Cancer; 1999 Aug; 82(5):640-3. PubMed ID: 10417759 [TBL] [Abstract][Full Text] [Related]
18. Diseases of Hereditary Renal Cell Cancers. Iliopoulos O Urol Clin North Am; 2023 May; 50(2):205-215. PubMed ID: 36948667 [TBL] [Abstract][Full Text] [Related]
19. Genetic basis of cancer of the kidney: disease-specific approaches to therapy. Linehan WM; Vasselli J; Srinivasan R; Walther MM; Merino M; Choyke P; Vocke C; Schmidt L; Isaacs JS; Glenn G; Toro J; Zbar B; Bottaro D; Neckers L Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6282S-9S. PubMed ID: 15448018 [TBL] [Abstract][Full Text] [Related]